This site is intended for healthcare professionals only
LoginRegister
Indian drug manufacturers benefit from Big Pharma interest beyond ChinaIndian drug manufacturers benefit from Big Pharma interest beyond China
Rusan Pharma launches State-of-the-Art facility for APIs in PithampurRusan Pharma launches State-of-the-Art facility for APIs in Pithampur
CDSCO Expert Panel Backs Akums Faropenem Dispersible Tablets, Grants CT, BE WaiversModify phase IV CT Protocol: CDSCO panel Tells Akums Pharma on FDC Bempedoic acid, Rosuvastatin...
Exemed Pharmaceuticals gets CDSCO panel Nod To Manufacture, Market Antidiabetic Drug Imeglimin HCl SR TabletsExemed Pharmaceuticals gets CDSCO panel Nod To Manufacture, Market Antidiabetic Drug Imeglimin HCl...
Torrent Pharma gets CDSCO Panel nod to study Brexpiprazole tablet to treat schizophreniaTorrent Pharma gets CDSCO Panel nod to study Brexpiprazole tablet to treat schizophrenia
Wockhardt posts profit of Rs 82 crore in Q2Wockhardt gets CDSCO Panel Nod to study antimicrobial FDC Cefepime plus Tazobactum
Novo Nordisk Wegovy approved by USFDA for adults with noncirrhotic MASH with liver fibrosisNovo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in...
Bayer invests 130 million EUR in new production facility for innovative parenteral productsBayer invests 130 million EUR in new production facility for innovative parenteral products
Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue SarcomaExclude patients above 65 years of age: CDSCO Panel Tells Sun Pharma on Eluxadoline trial
Ajanta Pharma Sets Up Wholly Owned Subsidiary in IrelandAjanta Pharma Gets CDSCO Panel Nod To Study Antihypertensive FDC
Bayer begins Phase I study with GIRK4 inhibitor for atrial fibrillationBayer Monsanto hit with USD 165 million verdict over PCBs in Seattle school
Novo Nordisk Projects Oral Weight-Loss Pills to Take One-Third of GLP-1 Market by 2030Novo Nordisk to launch popular anti-obesity drug Wegovy in Japan
X